Xeris Biopharma Holdings, Inc. 0A8E.L Stock
Xeris Biopharma Holdings, Inc. Price Chart
Xeris Biopharma Holdings, Inc. 0A8E.L Financial and Trading Overview
| Xeris Biopharma Holdings, Inc. stock price | 1.91 USD |
| Previous Close | 2.84 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 3 USD |
| Volume | 10.41K USD |
| Avg. Volume | 9.96K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.416 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0A8E.L Valuation Measures
| Enterprise Value | 474.74M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 12.16895 |
| Enterprise Value/Revenue | 3.911 |
| Enterprise Value/EBITDA | -10.49 |
Trading Information
Xeris Biopharma Holdings, Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 56.21% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 2.51 USD |
| 200-Day Moving Average | 1.8 USD |
0A8E.L Share Statistics
| Avg. Volume (3 month) | 9.96K USD |
| Avg. Daily Volume (10-Days) | 5.98K USD |
| Shares Outstanding | N/A |
| Float | 124.86M |
| Short Ratio | N/A |
| % Held by Insiders | 2.71% |
| % Held by Institutions | 42.71% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -64.085% |
| Operating Margin (ttm) | -47.41% |
| Gross Margin | 82.13% |
| EBITDA Margin | -37.28% |
Management Effectiveness
| Return on Assets (ttm) | -10.91% |
| Return on Equity (ttm) | -122.96% |
Income Statement
| Revenue (ttm) | 121.37M USD |
| Revenue Per Share (ttm) | 0.89 USD |
| Quarterly Revenue Growth (yoy) | 50.39% |
| Gross Profit (ttm) | 87.61M USD |
| EBITDA | -45258000 USD |
| Net Income Avi to Common (ttm) | -77780000 USD |
| Diluted EPS (ttm) | -1.416 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 95.1M USD |
| Total Cash Per Share (mrq) | 0.69 USD |
| Total Debt (mrq) | 198.42M USD |
| Total Debt/Equity (mrq) | 660.33 USD |
| Current Ratio (mrq) | 2.033 |
| Book Value Per Share (mrq) | 0.219 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -80622000 USD |
| Levered Free Cash Flow (ttm) | -33045876 USD |
Profile of Xeris Biopharma Holdings, Inc.
| Country | United Kingdom |
| State | IL |
| City | Chicago |
| Address | 180 North LaSalle Street |
| ZIP | 60601 |
| Phone | 844 445 5704 |
| Website | https://www.xerispharma.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 355 |
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Q&A For Xeris Biopharma Holdings, Inc. Stock
What is a current 0A8E.L stock price?
Xeris Biopharma Holdings, Inc. 0A8E.L stock price today per share is 1.91 USD.
How to purchase Xeris Biopharma Holdings, Inc. stock?
You can buy 0A8E.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xeris Biopharma Holdings, Inc.?
The stock symbol or ticker of Xeris Biopharma Holdings, Inc. is 0A8E.L.
How many shares does Xeris Biopharma Holdings, Inc. have in circulation?
The max supply of Xeris Biopharma Holdings, Inc. shares is 0.
What is Xeris Biopharma Holdings, Inc. Price to Earnings Ratio (PE Ratio)?
Xeris Biopharma Holdings, Inc. PE Ratio is now.
What was Xeris Biopharma Holdings, Inc. earnings per share over the trailing 12 months (TTM)?
Xeris Biopharma Holdings, Inc. EPS is -1.416 USD over the trailing 12 months.